NO20021476L - Farmasöytisk b¶rerformulering - Google Patents

Farmasöytisk b¶rerformulering

Info

Publication number
NO20021476L
NO20021476L NO20021476A NO20021476A NO20021476L NO 20021476 L NO20021476 L NO 20021476L NO 20021476 A NO20021476 A NO 20021476A NO 20021476 A NO20021476 A NO 20021476A NO 20021476 L NO20021476 L NO 20021476L
Authority
NO
Norway
Prior art keywords
pharmaceutical
borer
formulation
fatty acid
acid esters
Prior art date
Application number
NO20021476A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021476D0 (no
Inventor
Joseph Kyuwung Yoon
Richard William Saunders
Mahdi Bakir Fawzi
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO20021476D0 publication Critical patent/NO20021476D0/no
Publication of NO20021476L publication Critical patent/NO20021476L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20021476A 1999-09-27 2002-03-25 Farmasöytisk b¶rerformulering NO20021476L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40616499A 1999-09-27 1999-09-27
PCT/US2000/026381 WO2001022942A1 (en) 1999-09-27 2000-09-26 Pharmaceutical carrier formulation

Publications (2)

Publication Number Publication Date
NO20021476D0 NO20021476D0 (no) 2002-03-25
NO20021476L true NO20021476L (no) 2002-04-16

Family

ID=23606801

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021476A NO20021476L (no) 1999-09-27 2002-03-25 Farmasöytisk b¶rerformulering

Country Status (18)

Country Link
EP (1) EP1216029A1 (ja)
JP (1) JP2003510267A (ja)
KR (1) KR20020064289A (ja)
CN (1) CN1399542A (ja)
AR (1) AR025867A1 (ja)
AU (1) AU7716100A (ja)
BR (1) BR0014308A (ja)
CA (1) CA2388471A1 (ja)
CZ (1) CZ20021082A3 (ja)
EA (1) EA200200415A1 (ja)
HK (1) HK1044485A1 (ja)
HU (1) HUP0202652A3 (ja)
IL (1) IL148543A0 (ja)
MX (1) MXPA02003190A (ja)
NO (1) NO20021476L (ja)
PL (1) PL354331A1 (ja)
WO (1) WO2001022942A1 (ja)
ZA (1) ZA200203311B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
JPWO2004073692A1 (ja) * 2003-02-18 2006-06-01 山下　伸二 難水溶性薬物のハードカプセル剤
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
US8293270B2 (en) 2005-10-26 2012-10-23 Banner Pharmacaps, Inc. Lipophilic vehicle-based dual controlled release matrix system
US20100093725A1 (en) * 2006-10-31 2010-04-15 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
ES2944116T3 (es) * 2017-12-20 2023-06-19 Firmenich & Cie Composiciones para el cuidado bucal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
AU1911095A (en) * 1994-02-18 1995-09-04 Cephalon, Inc. Aqueous indolocarbazole solutions
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
EP1216029A1 (en) 2002-06-26
AR025867A1 (es) 2002-12-18
PL354331A1 (en) 2004-01-12
AU7716100A (en) 2001-04-30
HUP0202652A2 (hu) 2004-05-28
HUP0202652A3 (en) 2004-06-28
BR0014308A (pt) 2002-05-21
HK1044485A1 (zh) 2002-10-25
KR20020064289A (ko) 2002-08-07
WO2001022942A1 (en) 2001-04-05
CZ20021082A3 (cs) 2002-06-12
IL148543A0 (en) 2002-09-12
CN1399542A (zh) 2003-02-26
MXPA02003190A (es) 2002-09-30
ZA200203311B (en) 2003-12-31
JP2003510267A (ja) 2003-03-18
EA200200415A1 (ru) 2002-10-31
NO20021476D0 (no) 2002-03-25
CA2388471A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
CY1114631T1 (el) Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο
WO1998040069A3 (en) Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
ECSP045496A (es) "preparaciones acidas de insulina con estabilidad mejorada"
IE871335L (en) Steroid formulations.
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
CA2081068A1 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
EP0215423A3 (en) Transdermally resorbable aqueous compositions of arylpropionic-acid derivatives and process for their preparation
RU2003132426A (ru) Фармацевтический раствор арипипразола для орального применения
WO1998020872B1 (en) Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
CA2337745A1 (en) Human growth hormone aqueous formulation
PT918507E (pt) Formulacoes em aerossol
CA2519351A1 (en) Controlled release system
MX9204382A (es) Composiciones
NO20021476L (no) Farmasöytisk b¶rerformulering
EP1886691A3 (en) A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
PE20030545A1 (es) Formulaciones de jarabe de ribavirina
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
WO2001022969A3 (en) Vasopressin agonist formulation and process
JP2003526680A5 (ja)
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations
NO20021475L (no) Vasopressinantagonist, formulering og fremgangsmåte
WO2001003774A3 (en) Pharmaceutical composition for the treatment of calcification

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application